Dachaigh › Luchd-obrach › Constellation Pharmaceuticals, Inc.
Constellation Pharmaceuticals, Inc.: Tuarastalan H-1B agus taic bhìosa
Chuir Constellation Pharmaceuticals, Inc. 7 iarrtasan cumha-obrach a-steach airson bhìosaichean H-1B agus bhìosaichean co-cheangailte ann am bliadhnaichean ionmhais 2023–2026; le teisteanas: 7. Tuarastal meadhanach a chaidh a thabhann: $174,000.
A bheil Constellation Pharmaceuticals, Inc. a’ toirt taic do bhìosaichean H-1B?
Chuir Constellation Pharmaceuticals, Inc. 7 iarrtasan cumha-obrach a-steach ann am bliadhnaichean ionmhais 2023–2026, an tè as ùire air a chur a-steach air 23 Dàmh 2024. Is e LCA a’ chiad cheum ann an iarrtas H-1B, mar sin tha an neach-fastaidh air taic a thoirt do luchd-obrach H-1B no air ullachadh airson sin a dhèanamh; cha gharantaich e taic airson dreuchd shònraichte sam bith. Thoir sùil air liostaichean obrach an neach-fastaidh fhèin.
Iarrtasan cairt uaine (PERM) aig Constellation Pharmaceuticals, Inc.: 3 →
Tuarastalan a rèir tiotal obrach
| Tiotal dreuchd | LCAs | Tuarastal meadhanach |
|---|---|---|
| Assoc Dir., Drug Product Development & Technical Operations | 3 | $174,000 |
| Associate Director, CMC Analytical Development & QC | 1 | $172,414 |
| Associate Director, CMC Analytical Development | 1 | $185,000 |
| Associate Director, Clinical Quality Assurance / GCP QA | 1 | $167,154 |
| Sr Scientist I, CMC Ops and Planning | 1 | $137,000 |
Iarrtasan a rèir bliadhna ionmhais
| Bliadhna mhaoine | LCAs | Tuarastal meadhanach |
|---|---|---|
| FY2023 | 4 | $174,000 |
| FY2024 | 2 | $176,077 |
| FY2025 | 1 | $137,000 |
Ìrean tuarastail làithreach
Suidhichidh Roinn an Obrach ceithir ìrean tuarastail làithreach airson gach dreuchd agus sgìre, bho Ìre I (inntrigeadh) gu Ìre IV (gu tur comasach). Taghaidh an neach-fastaidh an ìre a fhreagras ri riatanasan na h-obrach.
Far a bheil na h-obraichean
Dreuchdan
- Chemists3
- Industrial Production Managers2
- Regulatory Affairs Managers1
- Health and Safety Engineers, Except Mining Safety Engineers and Inspectors1
Iarrtasan as ùire
| Tiotal dreuchd | Tuarastal bunasach | Àite | Air a chur a-steach | Ceann-latha tòiseachaidh | Inbhe |
|---|---|---|---|---|---|
| Sr Scientist I, CMC Ops and Planning | $137,000 Ìre III | Wilmington, MA | 23 Dàmh 2024 | 11 Màrt 2025 | Dearbhaichte |
| Associate Director, Clinical Quality Assurance / GCP QA | $167,154 | Issaquah, WA | 16 Sult 2024 | 8 Samh 2024 | Dearbhaichte |
| Associate Director, CMC Analytical Development | $185,000 Ìre III | Boston, MA | 4 Dàmh 2023 | 1 Gearr 2024 | Dearbhaichte |
| Assoc Dir., Drug Product Development & Technical Operations | $174,000 Ìre IV | Chester Springs, PA | 12 Ògmh 2023 | 30 Ògmh 2023 | Dearbhaichte |
| Assoc Dir., Drug Product Development & Technical Operations | $174,000 Ìre IV | Mason, OH | 14 Gearr 2023 | 27 Màrt 2023 | Dearbhaichte |
| Assoc Dir., Drug Product Development & Technical Operations | $174,000 | Mason, OH | 14 Gearr 2023 | 27 Màrt 2023 | Dearbhaichte |
| Associate Director, CMC Analytical Development & QC | $172,414 Ìre III | Boston, MA | 25 Dàmh 2022 | 25 Dàmh 2022 | Dearbhaichte |
Is e na tuarastalan an ìre as ìsle den tuarastal a chaidh a thabhann air gach iarrtas, air an tionndadh gu suim bhliadhnail; cleachdaidh na staitistigean iarrtasan làn-aimsire le teisteanas a-mhàin. Chan eil LCA na aontachadh bhìosa agus faodaidh aon LCA còmhdach a dhèanamh air iomadh dreuchd. Stòr: Roinn an Obrach na SA, Dàta Foillseachaidh OFLC LCA, bliadhnaichean ionmhais 2023–2026 (co-dhùnadh as ùire 30 Ògmh 2026).